-+ 0.00%
-+ 0.00%
-+ 0.00%

Maxim Group Maintains Buy on Health In Tech, Lowers Price Target to $3

Benzinga·08/14/2026 20:18:27
Listen to the news
Maxim Group analyst Allen Klee maintains Health In Tech (NASDAQ:HIT) with a Buy and lowers the price target from $4 to $3.